Medable

medable.com · Palo Alto, United States of America

Medable is a technology company that provides a decentralized clinical trial platform used by pharmaceutical, biotech, and clinical research organizations to design, run, and monitor clinical studies with remote and hybrid participation. Its cloud-based software supports eConsent, telehealth visits, patient-reported outcomes, and data collection to streamline trial operations and improve patient recruitment and retention. Medable generates revenue through subscription and usage-based fees for its SaaS platform and related implementation and support services.

Revenue
$50M - $250M
Employees
201 - 1,000
Founded
2015
Headquarters
Palo Alto, United States of America

Medable customers on Arbolus

Total customers 26 25 current · 1 former
Reviews growth 15 new reviews since Mar 2026

Customers who reviewed Medable

Seniority of Medable customers

Most people who reviewed Medable hold Director roles (56%), followed by C-Suite (40%) and Manager (4%).

  • Director 56%
  • C-Suite 40%
  • Manager 4%

Customers sample

Data Leader Manager NPS 10 Will renew
Other Partner Not specified NPS 10
Executive C-Suite NPS 9 Will renew

Employer names and spend open once the report publishes.

What 26 Arbolus experts think of Medable

Overall sentiment: Neutral

NPS scores are highly polarized: 32% Promoters (NPS 9–10), 41% Passive (NPS 7–8), 27% Detractors (NPS 0–6). Renewal intent is split: all high spenders are definite renewals; the remainder shows uncertainty or negative intent. Implementation stages vary, with a majority (>50%) at more than 1 year maturity, some in pilot, and a small segment offboarding. Key themes are a clear spend-sentiment link and a prominent gap between long-term happy customers and those with unmet expectations.

Tell us when the Medable report publishes.

We'll email you once the full customer report is ready, with employer names, spend and every written answer. No account needed.

Sentiment

7 Net Promoter Score, from 26 scored reviews
  • Promoters 9
  • Passives 10
  • Detractors 7

Written answers and themes publish with the full report.

Renewal intent

Plan to renew 46%
  • Will renew 6
  • Undecided 5
  • Not renewing 2

Plan to renew, by seniority

  • C-Suite 33% 6 answers
  • Director 50% 6 answers
  • Manager 100% 1 answer
  • 9/10 Average score from customers who will renew
  • 6/10 Average score from undecided customers
  • 4.5/10 Average score from customers not renewing

Top alternatives

Most weighed by Medable customers

For people who use Medable

Do you use Medable at work?

Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.

  • 26 customers of Medable have already contributed

Takes a few minutes. Your identity stays anonymous.